These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2329571)

  • 21. New lipoxygenase inhibitors isolated from Chinese plants. Development of new anti-allergic drugs.
    Murota S; Koshihara Y
    Drugs Exp Clin Res; 1985; 11(9):641-4. PubMed ID: 3880051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid esters.
    Musser JH; Kubrak DM; Chang J; DiZio SM; Hite M; Hand JM; Lewis AJ
    J Med Chem; 1987 Feb; 30(2):400-5. PubMed ID: 3806620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and 5-lipoxygenase inhibitory activities of eicosanoid compounds.
    Arai Y; Shimoji K; Konno M; Konishi Y; Okuyama S; Iguchi S; Hayashi M; Miyamoto T; Toda M
    J Med Chem; 1983 Jan; 26(1):72-8. PubMed ID: 6298421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationships of a novel class of 5-lipoxygenase inhibitors. 2-(Phenylmethyl)-4-hydroxy-3,5-dialkylbenzofurans: the development of L-656,224.
    Lau CK; Bélanger PC; Scheigetz J; Dufresne C; Williams HW; Maycock AL; Guindon Y; Bach T; Dallob AL; Denis D
    J Med Chem; 1989 Jun; 32(6):1190-7. PubMed ID: 2542553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological characterization of a series of leukotriene analogues with antagonist and agonist activities.
    Bernstein PR; Vacek EP; Adams EJ; Snyder DW; Krell RD
    J Med Chem; 1988 Mar; 31(3):692-6. PubMed ID: 2831366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The anti-SRS-A effect of tetrandrine].
    Zhang HQ; Bian RL
    Yao Xue Xue Bao; 1984 Aug; 19(8):616-8. PubMed ID: 6536169
    [No Abstract]   [Full Text] [Related]  

  • 27. 5-Lipoxygenase inhibitors: the synthesis and structure-activity relationships of a series of 1-phenyl-3-pyrazolidinones.
    Hlasta DJ; Casey FB; Ferguson EW; Gangell SJ; Heimann MR; Jaeger EP; Kullnig RK; Gordon RJ
    J Med Chem; 1991 May; 34(5):1560-70. PubMed ID: 1903450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antiallergic activity of a novel series of 5-lipoxygenase inhibitors.
    Kees KL; Musser JH; Chang J; Skowronek M; Lewis AJ
    J Med Chem; 1986 Nov; 29(11):2329-34. PubMed ID: 2878078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Leukotrienes and other products of lipoxygenases. Nature and biological profile].
    Gimeno AL
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):67-92. PubMed ID: 2998154
    [No Abstract]   [Full Text] [Related]  

  • 30. [(Arylpiperazino-4-butyryl)-6 benzoxazolinones and reduction products: chemistry and pharmacodynamic study].
    Moussavi Z; Bonte JP; Lesieur D; Leinot M; Lamar JC; Tisne-Versailles J
    Farmaco; 1989 Jan; 44(1):77-88. PubMed ID: 2742723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imidodisulfamides. 2. Substituted 1,2,3,4-tetrahydroisoquinolinylsulfonic imides as antagonists of slow-reacting substance of anaphylaxis.
    Ali FE; Gleason JG; Hill DT; Krell RD; Kruse CH; Lavanchy PG; Volpe BW
    J Med Chem; 1982 Oct; 25(10):1235-40. PubMed ID: 7143363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substituted (aryloxy)alkanoic acids as antagonists of slow-reacting substance of anaphylaxis.
    LeMahieu RA; Carson M; Han RJ; Nason WC; O'Donnell M; Brown DL; Crowley HJ; Welton AF
    J Med Chem; 1987 Jan; 30(1):173-8. PubMed ID: 3027332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereospecific synthesis, assignment of absolute configuration, and biological activity of the enantiomers of 3-[[[3-[2-(7-chloroquinolin-2-yl)-(E)-ethenyl]phenyl] [[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid, a potent and specific leukotriene D4 receptor antagonist.
    Gauthier JY; Jones T; Champion E; Charette L; Dehaven R; Ford-Hutchinson AW; Hoogsteen K; Lord A; Masson P; Piechuta H
    J Med Chem; 1990 Oct; 33(10):2841-5. PubMed ID: 2170650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wy-45,911: a novel leukotriene antagonist with lipoxygenase inhibitory activity.
    Musser JH; Kubrak DM; Chang J; Lewis AJ
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():536-9. PubMed ID: 2959109
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.
    Tomioka K; Yamada T; Mase T; Hara H; Murase K
    Arzneimittelforschung; 1988 May; 38(5):682-5. PubMed ID: 3415708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of arachidonate lipoxygenase substrates and inhibitors on SRS-A release in the guinea-pig lung [proceedings].
    Morris HR; Piper PJ; Taylor GW; Tippins JR
    Br J Pharmacol; 1979 Jul; 66(3):452P. PubMed ID: 118794
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of novel leukotriene--based anti-asthma drugs: MK-886 and MK-571.
    Young RN
    Agents Actions Suppl; 1991; 34():179-87. PubMed ID: 1793062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and structure-activity relationship studies of a series of 5-aryl-4,6-dithianonanedioic acids and related compounds: a novel class of leukotriene antagonists.
    Perchonock CD; Uzinskas I; McCarthy ME; Erhard KF; Gleason JG; Wasserman MA; Muccitelli RM; DeVan JF; Tucker SS; Vickery LM
    J Med Chem; 1986 Aug; 29(8):1442-52. PubMed ID: 3016267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity.
    Bird ; Bruneau P; Crawley GC; Edwards MP; Foster SJ; Girodeau JM; Kingston JF; McMillan RM
    J Med Chem; 1991 Jul; 34(7):2176-86. PubMed ID: 1648621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-(heterocyclic alkyl)pyrido[2,1-b]quinazoline-8-carboxamides as orally active antiallergy agents.
    Tilley JW; Levitan P; Lind J; Welton AF; Crowley HJ; Tobias LD; O'Donnell M
    J Med Chem; 1987 Jan; 30(1):185-93. PubMed ID: 2879917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.